skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer

Authors:
; ; ; ; ;
Publication Date:
Research Org.:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
OSTI Identifier:
1228994
Report Number(s):
BNL-111069-2015-JA
Journal ID: ISSN 0960-894X
DOE Contract Number:  
SC00112704
Resource Type:
Journal Article
Journal Name:
BioOrganic and Medicinal Chemistry Letters
Additional Journal Information:
Journal Volume: 22; Journal Issue: 10; Journal ID: ISSN 0960-894X
Country of Publication:
United States
Language:
English

Citation Formats

Chen, M, Adeniji, A, Twenter, B, Winkler, J, Christianson, D, and Penning, T. Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer. United States: N. p., 2012. Web. doi:10.1016/j.bmcl.2012.03.085.
Chen, M, Adeniji, A, Twenter, B, Winkler, J, Christianson, D, & Penning, T. Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer. United States. https://doi.org/10.1016/j.bmcl.2012.03.085
Chen, M, Adeniji, A, Twenter, B, Winkler, J, Christianson, D, and Penning, T. Thu . "Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer". United States. https://doi.org/10.1016/j.bmcl.2012.03.085.
@article{osti_1228994,
title = {Crystal Structures of AKR1C3 Containing an N-(aryl)amino-benzoate Inhibitor and a Bifunctional AKR1C3 Inhibitor and Androgen Receptor Antagonist. Therapeutic Leads for Castrate Resistant Prostate Cancer},
author = {Chen, M and Adeniji, A and Twenter, B and Winkler, J and Christianson, D and Penning, T},
abstractNote = {},
doi = {10.1016/j.bmcl.2012.03.085},
url = {https://www.osti.gov/biblio/1228994}, journal = {BioOrganic and Medicinal Chemistry Letters},
issn = {0960-894X},
number = 10,
volume = 22,
place = {United States},
year = {2012},
month = {3}
}